AbbVie Sale Purchase Of Stock from 2010 to 2024

ABBV Stock  USD 183.08  1.94  1.07%   
AbbVie Sale Purchase Of Stock yearly trend continues to be fairly stable with very little volatility. Sale Purchase Of Stock will likely drop to about -2.1 B in 2024. During the period from 2010 to 2024, AbbVie Sale Purchase Of Stock regression line of quarterly data had r-squared of  0.01 and coefficient of variation of (137.82). View All Fundamentals
 
Sale Purchase Of Stock  
First Reported
2013-03-31
Previous Quarter
-9 M
Current Value
-17 M
Quarterly Volatility
1.4 B
 
Yuan Drop
 
Covid
Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.1 B, Interest Expense of 1.1 B or Selling General Administrative of 7.8 B, as well as many indicators such as Price To Sales Ratio of 3.39, Dividend Yield of 0.0289 or PTB Ratio of 17.2. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.
  
Check out the analysis of AbbVie Correlation against competitors.

Latest AbbVie's Sale Purchase Of Stock Growth Pattern

Below is the plot of the Sale Purchase Of Stock of AbbVie Inc over the last few years. It is AbbVie's Sale Purchase Of Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AbbVie's overall financial position and show how it may be relating to other accounts over time.
Sale Purchase Of Stock10 Years Trend
Pretty Stable
   Sale Purchase Of Stock   
       Timeline  

AbbVie Sale Purchase Of Stock Regression Statistics

Arithmetic Mean(2,468,440,000)
Coefficient Of Variation(137.82)
Mean Deviation2,427,824,000
Median(978,000,000)
Standard Deviation3,401,989,500
Sample Variance11573532.6T
Range11.7B
R-Value(0.11)
Mean Square Error12311567.8T
R-Squared0.01
Significance0.69
Slope(84,072,143)
Total Sum of Squares162029455.9T

AbbVie Sale Purchase Of Stock History

2024-2.1 B
2023-2 B
2022-1.5 B
2021-934 M
2020-978 M
2019-629 M
2018-12 B

About AbbVie Financial Statements

AbbVie investors use historical fundamental indicators, such as AbbVie's Sale Purchase Of Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in AbbVie. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Sale Purchase Of Stock-2 B-2.1 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.